ニュース

HONG KONG, Aug 8, 2025 - ( JCN Newswire ) - Everest Medicines (HKEX 1952.HK) recently announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON(R) ...
SinoMed has made significant progress in innovative new products development recently, just before the Breakthrough Device Designation, the company’s HT Supreme™ Drug Coated Coronary Stent System ...
最新の国際 U.S. Food and Drug Administration ニュースとビューは、世界最大の通信社の一つであるロイターが提供しています。